Skip to main content

Month: August 2022

Solstice Announces $1.1 Million Flow-Through Share and Unit Financing

Red Lake Drill Program Expanded VANCOUVER, British Columbia, Aug. 08, 2022 (GLOBE NEWSWIRE) — Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) is pleased to announce that it intends to complete a financing by way of a non-brokered private placement for aggregate proceeds of $1.1 million subject to increase at the discretion of the board of directors of the Company (the “Offering”). Offering participation will be led by members of the management team, board of directors and a new institutional investor. The Offering will consist of: (i) common shares of the Company (the “National Flow-Through Shares”) that qualify as flow-through shares for purposes of the Income Tax Act (Canada) (the “ITA”) at a price of $0.13 per National Flow-Through Share; (ii) common shares of the Company (the “Ontario Flow-Through...

Continue reading

Global Warming Solutions, Inc. to introduce – Land & Ocean Smart Integrated Renewable Energy (LOSIRE) Solution

Temecula, CA, Aug. 08, 2022 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc., (OTC: GWSO), in the quest to find new, innovative, and more efficient, low-cost, flexible, and reliable solutions to provide zero carbon emission energy, is ready to start developing its latest revolutionary and transformative technology, a technology that combines the finished Hybrid Electrochemical System (commonly known as Hydrogen Battery or HES) manufactured by AQST, Inc. USA with the new Ocean Current Energy Device System. An integrated solution designed to expand possibilities and create new opportunities to produce reliable and efficient 100% clean energy, without affecting the environment and aesthetic of the location to be operated. This new GWSO technology to be developed and manufactured by AQST consist of a device designed to harness the...

Continue reading

Iveda Awarded $3 Million in Taiwan Projects

MESA, Ariz., Aug. 08, 2022 (GLOBE NEWSWIRE) — Iveda (NASDAQ: IVDA), a worldwide provider of artificial intelligence (AI) video search, Internet of Things (IoT), video surveillance and smart city digital transformation technologies, today announces four signed contracts in Taiwan worth approximately $3 million gross revenues. These projects are in process and are slated to be completed by the end of 2022 calendar year. Iveda Taiwan will manage and see the projects to completion. The largest of the projects is for $2.7 million with a government agency to provide video security surveillance system at 61 locations countrywide. Iveda is unable to disclose the agency identity due to the sensitivity of the project and for security reasons. Iveda will provide networking equipment and interprocess communication (IPC) computers to assist...

Continue reading

Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M

ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received A$2,085,453.17 research and development (R&D) tax incentive refund relating to the financial year ended June 2021. The Australian Government R&D tax incentive encourages companies to engage in R&D benefiting Australia, by providing a tax offset of up to 43.5% (refundable) for eligible R&D activities. Released on authority of the Executive Chairman. FOR FURTHER INFORMATION PLEASE CONTACT:General:Ms Suzanne IrwinCompany Secretary+61 8 8150 7400CoSec@bionomics.com.au Investor Relations:Mr. Connor BernsteinVice President, Strategy and Corporate Development+1 (650) 524-5143cbernstein@bionomics.com.auAbout Bionomics LimitedBionomics...

Continue reading

Radware Reports Second Quarter 2022 Financial Results

Second Quarter 2022 Results and Financial HighlightsRevenue of $75.1 million, up 8% year–over–year Total ARR of $195 million, up 10% year-over-year Non-GAAP gross margin of 83.3% compared to 82.3% in the second quarter of last year Cash flow from operations of $31.5 million Non-GAAP EPS of $0.18; GAAP EPS of $0.07TEL AVIV, Israel, Aug. 08, 2022 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today announced its consolidated financial results for the second quarter ended June 30, 2022. “We delivered solid revenue and earnings results in the second quarter. Our solutions, which protect our customers’ most critical applications and data centers in real time against cyber-attacks, are more critical to their businesses than ever before,” said Roy Zisapel,...

Continue reading

360 DigiTech to Announce Second Quarter 2022 Unaudited Financial Results on August 18, 2022

SHANGHAI, China, Aug. 08, 2022 (GLOBE NEWSWIRE) — 360 DigiTech, Inc. (NASDAQ: QFIN) (“360 DigiTech” or the “Company”), a leading financial technology platform in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2022, after U.S. markets close on Thursday, August 18, 2022. 360 DigiTech’s management team will host an earnings conference call at 8:30 PM U.S. Eastern Time on Thursday, August 18, 2022 (8:30 AM Beijing Time on Friday, August 19).United States: +1-646-722-4977  Hong Kong: +852-3027-6500  Mainland China: 400-821-0637  International: +65-6408-5782  PIN: 22390058#  Please dial in 15 minutes before the call is scheduled to begin and provide the PIN to join the call. A telephone replay of the call will be available after...

Continue reading

Barrick Maintains Dividend of $0.20 Per Share for Q2

All amounts expressed in US dollars TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) today announced the declaration of a dividend of $0.20 per share in respect of performance for the second quarter of 2022. The dividend, which is unchanged from Q1, is consistent with the Company’s Performance Dividend Policy announced at the start of the year. The Q2 2022 dividend will be paid on September 15, 2022 to shareholders of record at the close of business on August 31, 2022.1   “On the back of our strong operating performance, we are once again able to provide a leading dividend yield to our shareholders, whilst still maintaining a strong balance sheet,” says senior executive vice-president and chief financial officer Graham Shuttleworth. “We believe this continues to show the benefit of the dividend...

Continue reading

eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical Officer

SAN DIEGO and REDWOOD CITY, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced it has appointed Douglas Warner, M.D., as chief medical officer. Dr. Warner will develop strategies to continue advancing eFFECTOR’s two clinical-stage STRIs into advanced and potentially registrational trials. “Dr. Warner has extensive experience in oncology therapeutic development, and his expertise designing and executing clinical trials across all developmental stages, especially Phase 3, will be invaluable as we continue to advance our pipeline in a range of cancers,” said Steve Worland, Ph.D., president and chief executive officer of eFFECTOR. “We are very excited to welcome him to the...

Continue reading

Festi hf.: Buy-back programme week 31

In week 31 2022 Festi purchased in total 415,000 own shares for total amount of 92,070,000 ISK as follows:Week Date Time Purchased shares Price Purchase price Total shares bought Total puchase price31 02/08/2022 13.19.22 90.000 223 20.070.000 3.415.000 774.895.00031 03/08/2022 13.14.47 75.000 222 16.650.000 3.490.000 791.545.00031 08/04/2022 15.11.13 100.000 222 22.200.000 3.590.000 813.745.00031 08/05/2022 13.16.02 75.000 221 16.575.000 3.665.000 830.320.00031 08/05/2022 14.42.06 75.000 221 16.575.000 3.740.000 846.895.000      415.000   92.070.000    The execution the buy-back programme is in accordance with Chapter VIII of the Company Act No 2/1995 and annex II to the Regulation on insider information and market abuse No 630/2005. Before the purchase Festi held no shares in the company. Festi has now bought in...

Continue reading

Iceland Seafood International hf: Iceland Seafood’s outlook range for 2022 Normalised PBT revised to €9.0-14.0m

Draft 1H 2022 interim accounts indicate a loss before tax of €1.8m in the period As previously communicated, results in Q2 were significantly impacted by rapid and substantial price increases of all input factors in the period The IS UK operation is impacted by difficult external situation, it will take longer and cost more than previously estimated to stabilize the business Good performance of the Value Added S-Europe and the Sales & Distribution divisions continued in the period   Draft results of Iceland Seafood international interim accounts for 1H 2022 indicate a loss before tax of €1.8m. As expected and communicated when Q1 2022 results were published, significant and rapid price increases in all areas negatively impacted results in Q2, especially in the Value Added N-Europe division. That division mostly relies on sales to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.